OrbiMed Capital GP VIII LLC
Insider CIK 1845804 · TRAW 10% owner · DBTX Director, 10% owner · KNTE Director, 10% owner · IRON Director, 10% owner · JANX Director · BLSM Director · SCTX Director · AVBP Director, 10% owner · NONE Director · UPB Director, 10% owner · SION Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,049,283 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,039,996 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | P Buy | 2026-08-10 | 2026-08-12 | 625,000 | $16.00 | $10.00M | 2,714,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,049,283 | — | $0 | 2,089,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,039,996 | — | $0 | 1,039,996 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,049,283 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,039,996 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | P Buy | 2026-08-10 | 2026-08-12 | 625,000 | $16.00 | $10.00M | 2,714,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,049,283 | — | — | 2,089,279 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-12 | 1,039,996 | — | — | 1,039,996 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 2,065,672 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 348,825 | — | $0 | 348,825 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 1,000,000 | $15.00 | $15.00M | 1,348,825 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion deriv | 2026-07-27 | 2026-07-29 | 2,065,672 | — | $0 | 0 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | P Buy | 2026-07-27 | 2026-07-29 | 1,000,000 | $15.00 | $15.00M | 1,348,825 | SEC↗ |
| SCTX Scribe Therapeutics, Inc. | C Conversion | 2026-07-27 | 2026-07-29 | 348,825 | — | — | 348,825 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-07-07 | 2026-07-09 | 85,918 | $44.86 | $3.85M | 2,469,959 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 115,844 | $45.50 | $5.27M | 2,555,877 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-05-27 | 2026-05-29 | 101 | $44.49 | $4.5K | 2,671,721 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-05-11 | 2026-05-11 | 184,639 | $46.22 | $8.53M | 2,671,822 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 59,767 | $44.58 | $2.66M | 2,856,461 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 48,546 | $44.61 | $2.17M | 2,916,228 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-04-18 | 2026-04-21 | 2,948 | $44.52 | $131.2K | 2,964,774 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-04-17 | 2026-04-21 | 52,397 | $44.68 | $2.34M | 2,967,722 | SEC↗ |
| TRAW Traws Pharma, Inc. | P Buy deriv | 2026-04-16 | 2026-04-28 | 597,729 | — | $0 | 597,729 | SEC↗ |
| TRAW Traws Pharma, Inc. | P Buy deriv | 2026-04-16 | 2026-04-28 | 597,729 | — | $0 | 597,729 | SEC↗ |
| TRAW Traws Pharma, Inc. | P Buy deriv | 2026-04-16 | 2026-04-28 | 1,793,187 | — | $0 | 1,793,187 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-04-16 | 2026-04-16 | 226,906 | $45.34 | $10.29M | 3,020,119 | SEC↗ |
| TRAW Traws Pharma, Inc. | P Buy | 2026-04-16 | 2026-04-28 | 597,729 | $1.67 | $998.2K | 1,203,250 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-16 | 235,863 | $44.64 | $10.53M | 3,247,025 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-16 | 47,814 | $44.51 | $2.13M | 3,482,888 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-04 | 29,063 | $44.58 | $1.30M | 3,530,702 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 1,890 | $44.57 | $84.2K | 3,559,765 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-12-24 | 2025-12-29 | 33,356 | $44.55 | $1.49M | 3,561,655 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-12-19 | 2025-12-19 | 875 | $44.49 | $38.9K | 3,595,011 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-12-18 | 2025-12-19 | 100 | $44.49 | $4.4K | 3,595,886 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-12-17 | 2025-12-19 | 900 | $44.50 | $40.0K | 3,595,986 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-26 | 2025-11-26 | 1,600 | $44.49 | $71.2K | 3,596,886 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-25 | 2025-11-26 | 11,890 | $44.60 | $530.3K | 3,598,486 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-24 | 2025-11-26 | 94,583 | $44.54 | $4.21M | 3,610,376 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 1,956 | $54.11 | $105.8K | 482,308 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 3,026 | $54.11 | $163.7K | 746,171 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 756 | $54.11 | $40.9K | 186,541 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 1,320 | $54.00 | $71.3K | 187,297 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 5,279 | $54.00 | $285.1K | 749,197 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-21 | 2025-03-21 | 3,412 | $54.00 | $184.2K | 484,264 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 364 | $54.01 | $19.7K | 188,617 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 1,457 | $54.01 | $78.7K | 754,476 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 941 | $54.01 | $50.8K | 487,676 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 5,228 | $54.02 | $282.4K | 188,981 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 20,911 | $54.02 | $1.13M | 755,933 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-19 | 2025-03-21 | 13,517 | $54.02 | $730.2K | 488,617 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 10,733 | $54.44 | $584.3K | 194,209 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 603 | $55.05 | $33.2K | 529,884 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 933 | $55.05 | $51.4K | 819,774 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 233 | $55.05 | $12.8K | 204,942 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 42,930 | $54.44 | $2.34M | 776,844 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-12 | 2025-03-12 | 27,750 | $54.44 | $1.51M | 502,134 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 9,222 | $54.01 | $498.1K | 530,487 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 14,267 | $54.01 | $770.6K | 820,707 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-11 | 2025-03-12 | 3,567 | $54.01 | $192.7K | 205,175 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 68,766 | $54.29 | $3.73M | 539,845 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 106,384 | $54.29 | $5.78M | 835,185 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 26,596 | $54.29 | $1.44M | 208,795 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 136 | $55.01 | $7.5K | 539,709 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 211 | $55.01 | $11.6K | 834,974 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 53 | $55.01 | $2.9K | 208,742 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,560,951 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 2,048,760 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | P Buy | 2025-02-10 | 2025-02-10 | 550,000 | $18.00 | $9.90M | 3,704,959 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 3,154,959 | — | $0 | 3,154,959 | SEC↗ |
| TRAW Traws Pharma, Inc. | P Buy deriv | 2024-12-29 | 2025-01-27 | 96,348 | — | $0 | 96,348 | SEC↗ |
| TRAW Traws Pharma, Inc. | P Buy deriv | 2024-12-29 | 2025-01-27 | 96,348 | — | $0 | 96,348 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 215,146 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 389,078 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 230,753 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 74,613 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion deriv | 2024-11-01 | 2024-11-05 | 323,916 | — | $0 | 0 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 215,146 | $3.20 | $688.5K | 539,062 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 230,753 | $3.60 | $830.7K | 1,158,893 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 74,613 | $3.60 | $268.6K | 1,233,506 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 808,894 | $4.00 | $3.24M | 2,042,400 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 479,736 | $4.00 | $1.92M | 2,522,136 | SEC↗ |
| NONE Lomond Therapeutics Holdin | A Award | 2024-11-01 | 2024-11-05 | 155,120 | $4.00 | $620.5K | 2,677,256 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 389,078 | $3.60 | $1.40M | 928,140 | SEC↗ |
| NONE Lomond Therapeutics Holdin | C Conversion | 2024-11-01 | 2024-11-05 | 323,916 | $3.20 | $1.04M | 323,916 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 524,500 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 2,098,000 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 197,456 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion deriv | 2024-10-15 | 2024-10-17 | 789,833 | — | $0 | 0 | SEC↗ |
| UPB Upstream Bio, Inc. | P Buy | 2024-10-15 | 2024-10-17 | 660,000 | $17.00 | $11.22M | 4,554,873 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion | 2024-10-15 | 2024-10-17 | 721,956 | — | $0 | 973,716 | SEC↗ |
| UPB Upstream Bio, Inc. | P Buy | 2024-10-15 | 2024-10-17 | 165,000 | $17.00 | $2.81M | 1,138,716 | SEC↗ |
| UPB Upstream Bio, Inc. | C Conversion | 2024-10-15 | 2024-10-17 | 2,887,833 | — | $0 | 3,894,873 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 43,944 | $36.00 | $1.58M | 941,569 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 10,986 | $36.00 | $395.5K | 235,391 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2024-06-17 | 2024-06-20 | 28,404 | $36.00 | $1.02M | 608,611 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 84,599 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 450,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,338 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,339 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 4,738,453 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 821,827 | — | $0 | 821,827 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 469,615 | — | $0 | 1,291,442 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | P Buy | 2024-01-30 | 2024-01-31 | 222,222 | $18.00 | $4.00M | 1,513,664 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-20 | 1,724 | — | $0 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 1,724 | $59.24 | $102.1K | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | M Exercise | 2023-12-18 | 2023-12-20 | 1,724 | $38.00 | $65.5K | 1,724 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 100 | $57.73 | $5.8K | 1,126,125 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-14 | 100 | $57.73 | $5.8K | 727,807 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 228,500 | $56.75 | $12.97M | 897,625 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 57,100 | $56.75 | $3.24M | 224,405 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-14 | 2023-12-15 | 147,600 | $56.75 | $8.38M | 580,207 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 36,400 | $58.56 | $2.13M | 727,907 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 14,100 | $58.56 | $825.7K | 281,505 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-13 | 2023-12-14 | 56,200 | $58.56 | $3.29M | 1,126,225 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 3,600 | $60.16 | $216.6K | 295,605 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 9,300 | $60.16 | $559.5K | 764,307 | SEC↗ |
| IRON Disc Medicine, Inc. | S Sale | 2023-12-12 | 2023-12-14 | 14,400 | $60.16 | $866.3K | 1,182,425 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,512 | $2.82 | $1.38M | 1,368,339 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,511 | $2.82 | $1.38M | 1,368,338 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 312,991 | $2.75 | $860.7K | 4,738,453 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 220,610 | $2.67 | $589.0K | 4,425,462 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,544 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 467,068 | $2.62 | $1.22M | 4,204,852 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,545 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 228,754 | $2.55 | $583.3K | 3,737,784 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,997 | $2.55 | $155.5K | 610,997 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,998 | $2.55 | $155.5K | 610,998 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 37,049 | $23.00 | $852.1K | 773,607 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 57,318 | $23.00 | $1.32M | 1,196,825 | SEC↗ |
| IRON Disc Medicine, Inc. | P Buy | 2023-02-15 | 2023-02-17 | 14,329 | $23.00 | $329.6K | 299,205 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 284,876 | — | $0 | 284,876 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 153,936 | — | $0 | 736,558 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 582,622 | — | $0 | 582,622 | SEC↗ |
| IRON Disc Medicine, Inc. | J Other | 2022-12-29 | 2023-01-03 | 1,139,507 | — | $0 | 1,139,507 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2021-12-29 | 2021-12-30 | 3,700 | $20.30 | $75.1K | 231,098 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2021-12-29 | 2021-12-30 | 36,700 | $20.30 | $745.0K | 2,258,566 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2021-12-21 | 2021-12-23 | 11,100 | $19.00 | $210.9K | 234,798 | SEC↗ |
| JANX Janux Therapeutics, Inc. | S Sale | 2021-12-21 | 2021-12-23 | 108,300 | $19.00 | $2.06M | 2,295,266 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 128,609 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 643,046 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion deriv | 2021-06-15 | 2021-06-16 | 1,052,632 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2021-06-15 | 2021-06-16 | 588,203 | $17.00 | $10.00M | 2,760,366 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 164,748 | — | $0 | 164,748 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 823,742 | — | $0 | 2,172,163 | SEC↗ |
| JANX Janux Therapeutics, Inc. | C Conversion | 2021-06-15 | 2021-06-16 | 1,348,421 | — | $0 | 1,348,421 | SEC↗ |
| JANX Janux Therapeutics, Inc. | P Buy | 2021-06-15 | 2021-06-16 | 117,650 | $17.00 | $2.00M | 282,398 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 14,480,162 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,737,619 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,158,412 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 2,732,106 | — | $0 | 2,732,106 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 555,566 | $18.00 | $10.00M | 883,418 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 327,852 | — | $0 | 327,852 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 218,568 | — | $0 | 218,568 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 1,111,100 | $18.00 | $20.00M | 3,843,206 | SEC↗ |